Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: Relationship to lipoprotein (a) and low-density lipoprotein cholesterol levels

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 3, 1999, Pages 237-244

  Barth, Jay A ^a   Deckelbaum, Richard J ^a   Starc, Thomas J ^a   Shea, Steven ^a   Mosca, Lori ^a   Berglund, Lars ^a,b  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033104779     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90079-3     Document Type: Article

References (66)

1. 1. Gaubatz JW, Heidman C, Gotto AM, Morrisett JD, Dahlen GH. Human plasma lipoprotein(a): structural properties. J Biol Chem 1983;258:4582-9.
2. 2. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp (a) glycoprotein phenotypes: inheritance and relation to Lp (a)-lipoprotein concentrations in plasma. J Clin Invest 1987;80:358-65.
3. 3. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs H. Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentration. J Clin Invest 1992;90:52-60.
4. 4. Berg K, Dahlen G, Borresen AL. Lp (a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle-aged males. Clin Genet 1979;16:347-52.
5. 5. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici GB. Lipoprotein Lp (a) and the risk for myocardial infarction. Atherosclerosis 1981;38:51-61.
6. 6. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, et al. The association between serum Lp (a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986;62:249-57.
7. 7. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein Lp (a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74:758-65.
8. 8. Sandkamp M, Funke H, Schulte H, Kohler E, Assman G. Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990;36:20-3.
9. 9. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population of middle-aged men. Br Med J 1990;301:1248-51.
10. 10. Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Manttari M, Manninen V, et al. Lipoprotein(a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991;89:59-67.
11. 11. Sigurdsson G, Baldursdottir A, Sigvaldason H, Agnarsson U, Thorgeisson G, Sigfusson N. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol 1992;69:1251-4.
12. 12. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein (a) and the risk of myocardial infarction. JAMA 1993;270:2195-9.
13. 13. Simons L, Friedlander Y, Simons J, McCallum J. Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo Study. Atherosclerosis 1993;99:87-95.
14. 14. Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilehto J, et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994;106:9-19.
15. 15. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, et al. Lipoprotein(a) levels and the risk of coronary heart disease in men. JAMA 1994;271:999-1003.
16. 16. Bostom AG, Cupples LA, Jenner JL, Ordovas J, Seman L, Schaefer E, et al. Elevated plasma lipoprotein(a) and coronary heart disease in men 55 years and younger. JAMA 1996;276:544-8.
17. 17. Wild SH, Fortmann SP, Marcovina SM. A prospective case-control study of lipoprotein (a) levels and apo (a) size and risk of coronary heart disease in Stanford five-city project participants. Arterioscler Thromb Vasc Biol 1997;17:239-45.
18. 18. Kraft HG, Lingenhel A, Köchl S, Hoppichler F, Kronenberg F, Abe A, et al. Apolipoprotein (a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol 1996;16:713-9.
19. 19. Orth-Gomér K, Mittleman MA, Schenck-Gustafsson K, Wamala SP, Eriksson M, Belkic K, et al. Lipoprotein (a) as a determinant of coronary heart disease in young women. Circulation 1997;95:329-34.
20. 20. Houlston R, Quinley J, Mount J, Watts GF, Lewis B. Lipoprotein(a) and coronary artery disease in familial hypercholesterolemia. Lancet 1988;2:405.
21. 21. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR, Boerwinkle E, et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesteremia. N Engl J Med 1990;322:1494-9.
22. 22. Wiklund O, Angelin B, Olofsson SO, Eriksson M, Fager G, Berglund L, et al. Apolipoprotein (a) and ischemic heart disease in familial hypercholesterolaemia. Lancet 1990;335:1360-3.
23. 23. Mbewu AD, Bhatnagar D, Durrington PN, Hunt L, Ishola M, Arrol S, et al. Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations. Arterioscler Thromb 1991;11:940-6.
24. 24. Bowden JF, Pritchard PH, Hill JS, Frohlich JJ. Lp (a) concentration and apo(a) isoforom size. Relation to the presence of coronary artery disease in familial hypercholesterolemia. Arterioscler Thromb 1994;14:1561-8.
25. 25. Carmena R, Lussier-Cacan S, Roy M, Minnich A, Lingenhel A, Kronenberg F, et al. Lp (a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect. Arterioscler Thromb Vasc Biol 1996;16:129-36.
26. 26. Shea S, Ottman R, Gabrielli C. Family history as an independent risk factor for coronary artery disease. J Am Coll Cardiol 1984;4:793-801.
27. 27. Barrett-Connor E, Khaw K. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation 1984;69:1065-9.
28. 28. Schrott HG, Clarke WR, Wiebe DA, Connor WE, Lauer R. Increased coronary mortality in relations of hypercholesterolemic school children: The Muscatine Study. Circulation 1979;59:320-6.
29. 29. Glueck CJ, Fallat RW, Tsang R, Buncher CR. Hyperlipidemia in progeny of parents with myocardial infarction before age 50. Am J Dis Child 1974;127:70-5.
30. 30. Moll PP, Sing CF, Weidman WH, Gordon H, Ellefson RD, Hodgson PA, et al. Total cholesterol and lipoproteins in school children: prediction of coronary heart disease in adult relatives. Circulation 1983;67:127-34.
31. 31. Lee J, Lauer RM, Clarke WR. Lipoproteins in the progeny of young men with coronary artery disease: children with increased risk. Pediatrics 1986;78:330-7.
32. 32. Marquez A, Mendoza S, Carrasco H, Hamer T, Glueck CJ. High Lipoprotein(a) in children from kindreds with parental premature myocardial infarction. Pediatr Res 1993;34:670-4.
33. 33. Kostner GM, Czinner A, Pfeiffer KH, Bihari-Varga M. Lipoprotein(a) concentrations as risk indicators for atherosclerosis. Arch Dis Child 1991;66:1054-6.
34. 34. Wilcken DE, Wang XL, Greenwood J, Lynch J. Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents. J Pediatr 1993;123:519-26.
35. 35. Vella JC, Jover E. Relation to Lipoprotein(a) in 11-to 19-year-old adolescents to parental cardiovascular heart disease. Clin Chem 1993;39:477-80.
36. 36. Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS. Racial (black-white) differences in serum lipoprotein(a) distribution and its relation to parental myocardial infarction in children. Circulation 1991;84:160-7.
37. 37. Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH, Kostner GM. Lipoprotein Lp (a): a risk factor for myocardial infarction. Arteriosclerosis 1988;8:398-401.
38. 38. Bailleul S, Couderc R, Rossignol C, Fermanian J, Boutouchent F, Farnier MA, et al. Lipoprotein(a) in childhood: relation with other atherosclerosis risk factors and family history of atherosclerosis. Clin Chem 1995;41:241-5.
39. 39. Okada T, Sato Y, Yamazaki K, Iwata F, Hara M, Kim H, et al. Lipoprotein(a) and apolipoprotein A-l and B in school-children whose grandparents had coronary vascular events: a preliminary study of 12-13 year old Japanese children. Ada Paediatr Jpn 1995;37:582-7.
40. 40. Bergström F., Hernell O, Persson LA, Vcssby B. Scrum lipid values in adolescents are related to family history, infant feeding, and physical growth. Atherosclerosis 1995;! 17:1-13.
41. 4L NCEP Expert Panel on Blood Cholesterol Levels in Chil-dren and Adolescents. National Cholesterol Education Pro-gram: Highlights of the report of the expert panel on blood cholesterol in children and adolescents. Pediatrics 1992;89:495-511.
42. 42. Lopes-Virclla MF, Stone P, Ellis S, Col well JA. Choles-terol determination in high-density lipoprotein separated by three different methods. Clin Chem 1977;23:S82-4.
43. 43. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
44. 44. Gillery P, Arthuis P, Cuperlier C, Circaud R. Rate nephelometric assay of serum Lipoprotein(a). Clin Chem 1993;39:503-8.
45. 45. Tuck CH, Holleran S, Berglund L. Hormonal regulation of lipoprotein (a) levels: effects of estrogen replacement therapy on lipoprotein (a) and acute phase reactants in post-menopausal women. Arterioscler Thromb Vasc Biol 1997;17:1822-9.
46. 46. Kwiterovich PO. Identification and treatment of heterozygous familial hypercholesterolemia in children and adolescents. Am J Cardiol 1993;72:30D-7D.
47. 47. Berglund L, Carlstrom K, Stege R, Gottlieb C, Eriksson M, Angelin B, et al. Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males. J Clin Endocrinol Metab 1996;81:2633-7.
48. 48. Contois JH, Lammi-Keefe CJ, Vogel S, McNamara JR, Wilson PWF, Massov T, et al. Plasma lipoprotein(a) distribution in the Framingham Offspring Study as determined with a commercially available immunoturbidimetric assay. Clin Chim Acta 1996;253:21-35.
49. 49. Rainwater DL. Lp (a) concentrations are related to plasma lipid concentrations. Atherosclerosis 1996;127:13-8.
50. 50. Ohji T, Chiba K, Kohri T, Yamagishi M. Serum lipoprotein(a) in healthy Japanese children 5 years of age. Acta Paediatr Jpn 1993;35:302-5.
51. 51. Alberty R. Lipoprotein(a) concentration in various hyperlipidemias. Clin Chim Acta 1994;226:105-7.
52. 52. Friedlander Y, Leitersdorf E. Segregation analysis of plasma lipoprotein(a) levels in pedigrees with molecularly defined familial hypercholesterolemia. Genet Epidemiol 1995;12:129-43.
53. 53. Soutar AK, McCarthy SN, Seed M, Knight BL. Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the Pro6646Lcumutation in the LDL receptor gene. J Clin Invest 1992;88:483-92.
54. 54. Ghiselli G, Gaddi A, Barozzi G. Plasma lipoprotein(a) concentration in familial hypercholesterolemic patients without coronary artery disease. Metabolism 1992;41:833-8.
55. 55. Widhalm K, Genser D. Elevated levels of lipoprotein(a) in children with familial hypercholesterolemia. Wien Klin Wochenschr 1994;106:197-200.
56. 56. Rader DJ, Mann WA, Cain W. The low density lipoprotein receptor is not required for normal catabolism of Lp (a) in humans. J Clin Invest 1995;95:1403-8.
57. 57. Sorensen KE, Celermajcr DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. J Clin Invest 1994;93:50-5.
58. 58. Shannon B, Dixon LB, Tershakovec A, Bennett M, Coates P, Cortner J. Are lipoprotein(a), apo E phenotype, and family history of heart disease associated among 4 to 10 year old children with elevated LDL-cholesterol [abstract]? FASEB J 1996;10:A746.
59. 59. Cremer P, Nagel D, Labrot B, Mann H, Muche R, Elster H, et al. Lipoprotein Lp (a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS), Eur J Clin Invest 1994;24:444-53.
60. 60. Maher VMG, Brown BG, Marcovina SM, Hillger LA, Zhao XQ, Albers JJ. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein (a). JAMA 1995;274:1771-4.
61. 61. Guyton JR, Dahlen GH, Patsch W, Kautz JA, Gotto AM. Relationship of plasma lipoprotein Lp (a) levels to race and to apolipoprotein B. Arteriosclerosis 1985;5:265-72.
62. 62. Heyden S, Von Eckardstein A, Schulte H, Schneider K, Assmann G. Raised lipoprotein(a) in hypercholesterolemic black students compared to age-matched whites in North and South Carolina. Int J Epidemiol 1994;23:301-6.
63. 63. Moliterno DJ, Jokinen EV, Miserez AR, Lange RA, Willard JE, Boerwinkle E, et al. No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans, ArteriosclerThromb Vasc Biol 1995;15:850-5.
64. 64. Goff DC Jr, Ramsey DJ, Labarthe DR, Nichaman MZ. Acute myocardial infarction and coronary heart disease mortality among Mexican Americans and non-Hispanic whites in Texas, 1980 through 1989. Ethn Dis 1993;3:64-9.
65. 65. Harris-Hooker S, Sanford GL. Lipids, lipoproteins and coronary heart disease in minority populations. Atherosclerosis 1994;108(suppl):S83-104.
66. 66. Haffner SM, Gruber KK, Morales PA. Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. Am J Epidemiol 1992;136:1060-8.